ciprofloxacin has been researched along with Carcinoma, Anaplastic in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an in vitro study, the effect of ciprofloxacin was examined on proliferation of HT-29 human colon carcinoma cell line." | 7.69 | In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry. ( Dayan, D; Nyska, A; Rabau, M, 1995) |
| "In an in vitro study, the effect of ciprofloxacin was examined on proliferation of HT-29 human colon carcinoma cell line." | 3.69 | In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry. ( Dayan, D; Nyska, A; Rabau, M, 1995) |
| "Preincubation with subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim decreased the adherence of the respiratory pathogens Klebsiella pneumoniae, Haemophilus influenzae, and Moraxella (Branhamella) catarrhalis to human larynx carcinoma HEp-2 cells." | 3.68 | Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim. ( Beumer, H; Hoepelman, AI; Rozenberg-Arska, M; Verhoef, J; Visser, MR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Davary Avareshk, A | 1 |
| Jalal, R | 1 |
| Gholami, J | 1 |
| Bykowska, A | 1 |
| Komarnicka, UK | 1 |
| Jeżowska-Bojczuk, M | 1 |
| Kyzioł, A | 1 |
| Xue, H | 1 |
| Field, CJ | 1 |
| Sawyer, MB | 1 |
| Dieleman, LA | 1 |
| Baracos, VE | 1 |
| Crull, K | 1 |
| Weiss, S | 1 |
| Herold, C | 1 |
| Ganslmayer, M | 1 |
| Ocker, M | 1 |
| Blauberger, S | 1 |
| Zopf, S | 1 |
| Hahn, EG | 1 |
| Schuppan, D | 1 |
| Visser, MR | 1 |
| Beumer, H | 1 |
| Hoepelman, AI | 1 |
| Rozenberg-Arska, M | 1 |
| Verhoef, J | 1 |
| Rabau, M | 1 |
| Nyska, A | 1 |
| Dayan, D | 1 |
7 other studies available for ciprofloxacin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Ciprofloxacin; Doxorubicin; Humans; Male; Prosta | 2022 |
Cu
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt | 2018 |
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Phytogenic; Camptothe | 2009 |
Antibiotic control of tumor-colonizing Salmonella enterica serovar Typhimurium.
Topics: Animals; Anti-Infective Agents; Carcinoma; Ciprofloxacin; Colonic Neoplasms; Disease Models, Animal; | 2011 |
Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells.
Topics: Alitretinoin; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; | 2003 |
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Topics: Anti-Infective Agents; Bacteria; Bacterial Adhesion; Carcinoma; Ciprofloxacin; Fluoroquinolones; Hum | 1993 |
In vitro effect of ciprofloxacin on HT-29 human colon carcinoma cell line: assessment of cell proliferation by thymidine uptake and silver nucleolar organizer regions (AgNOR) histomorphometry.
Topics: Carcinoma; Cell Division; Cell Survival; Ciprofloxacin; Colonic Neoplasms; Humans; Nucleolus Organiz | 1995 |